SRSF2 and myelodysplastic syndrome: SRSF2 mutations are found in ~50% of chronic myelomonocytic leukemia (CMML), ~20% of MDS, and ~15% of AML patients and ~3–5% of healthy individuals with clonal hematopoiesis (CH).